Grants-pi
2023.08~2026.07 (Ongoing)
Ministry of Science and Technology (MOST)
Evaluate immuno-sensitization and radio-sensitization potential by long-acting interleukin-15 with albumin binding domain
Grant number: NSTC 112-2314-B-039-063-MY3
2023.01~2028.12 (Ongoing)
Ministry of Education (MOE) in Taiwan
“Drug Development Center, China Medical University" from The Featured Areas Research Center Program within the framework of the Higher Education Sprout Project.
2020.08~2023.07 (Closed)
Ministry of Science and Technology (MOST)
Evaluate therapeutic efficacy and mechanism of combination of poly ADP-ribose polymerase inhibitor with temozolomide, radiaiton or immune checkpoint inhibitor on glioblastoma
Grant number: MOST 109-2314-B-039 -021-MY3
2020.01~2020.12 (Closed)
Ministry of Education (MOE) in Taiwan
“Drug Development Center, China Medical University" from The Featured Areas Research Center Program within the framework of the Higher Education Sprout Project.
2019.09~2020.08 (Closed)
China Medical University-MOST match fund
Delivery of miRNA124 or miRNA145 and PD-1 dual expression vector to glioblastoma by Wharton’s Jelly mesenchymal stem cells suppress tumor progression
Grant number: CMU108-MF-23
2019.08~2022.02 (Closed)
Ministry of Science and Technology (MOST)
Delivery of miRNA124 or miRNA145 and PD-1 dual expression vector to glioblastoma by Wharton’s Jelly mesenchymal stem cells suppress tumor progression
Grant number: MOST 108-2314-B-039-007-MY3
2019.07~2020.02 (Closed)
Undergraduate Research Proposal Granted, Ministry of Science and Technology (MOST)
Therapeutic Efficacy and Mechanism Investigation for Hyperforin in Bladder Cancer Cells
Grant Number: 108-2813-C-039-097-B
2019.06~2020.07 (Closed)
China Medical University
Delivery of miRNA124 or miRNA145 and TRAIL or PD-1 dual expression vector by Wharton’s Jelly mesenchymal stem cells to suppress glioblastoma progression
Grant Number: CMU107-TU-05
2018.07~2020.07 (Closed)
Ministry of Science and Technology (MOST)
Therapeutic efficacy and mechanism investigation for imipramine in glioblastoma.
Grant Number: MOST 107-2314-B-039-068-MY2
2019.01~2019.12 (Closed)
Ministry of Education (MOE) in Taiwan
“Drug Development Center, China Medical University" from The Featured Areas Research Center Program within the framework of the Higher Education Sprout Project.
2018.11~2019.07 (Closed)
China Medical University
Therapeutic Efficacy and Mechanism Investigation for Imipramine in Non-small Cell Lung Cancer.
Grant Number: CMU107-N-26
2018.05~2018.04 (Closed)
Taipei Medical University
Trafficking the infiltration of iron oxide labeling placenta-derived mesenchymal stem cells on glioblastoma animal model by MRI
Grant Number: 107TMU-TMUH-18
2017.06~2018.07 (Closed)
Taipei Medical University
Establish MR radiogenmoic on human and animal.
Grant Number: TMU105-AE1-B49
2017.06~2018.05 (Closed)
Taipei Medical University/Taipei Medical University Hospital Grant
Using MR Theranostic Probe to Evaluate the Therapeutic Efficacy on Non-Small Cell Lung Cancer Brain Metastases.
Grant no: 106TMU-TMUH-27
2016.06~2017.05 (Closed)
Taipei Medical University/Taipei Medical University Hospital Grant
Regorafenib Enhances Efficacy of Temozolomide against Glioblastoma via Suppression of ERK/NF-kB Signaling Pathway
Grant Number: 105TMU-TMUH-23
2015.06~2016.05 (Closed)
Taipei Medical University/Taipei Medical University Hospital Grant
Radiogenomics of Malignant Gliomas by linking Physiological MR Imaging, Histopathological patterns, and Genetic alternations.
Grant Number: 104TMU-TMUH-23
Grants-co-pi
2023.08~2026.07 (Ongoing)
Ministry of Science and Technology (MOST)
The investigation of inhibitory efficacy and mechanism of quetiapine combines with radiation, lenvatinib, or immune checkpoint inhibitor in hepatocellular carcinoma
2023.08~2026.07 (Ongoing)
Ministry of Science and Technology (MOST)
Elucidate whether radio sensitization effect of lenvatinib is associates with inactivation of CXCL13/CXCR5/NF-κB in non-small cell lung cancer
2022.05~2024.04 (Ongoing)
Ministry of Science and Technology (MOST)
Allogeneic cell-based immunotherapy: using dual gene engineered mesenchymal stem cell and mRNA modified CAR gamma-delta T for precision solid tumor treatment
2022.08~2025.07 (Ongoing)
Ministry of Science and Technology (MOST)
Investigate treatment efficacy and Src-mediated signaling transduction of lenvatinib combined with radiotherapy and immune checkpoint inhibitor on Hepatocellular carcinoma
2022.05~2023.04 (Closed)
Ministry of Science and Technology (MOST)
Allogeneic cell-based immunotherapy: using dual gene engineered mesenchymal stem cell and mRNA modified CAR gamma-delta T for precision solid tumor treatment
2021.08~2022.07 (Closed)
Ministry of Science and Technology (MOST)
Evaluation of anticancer efficacy and mechanism of magnolol combined with immune checkpoint inhibitors in hepatocellular carcinoma
2020.08~2021.07 (Closed)
Ministry of Science and Technology (MOST)
Exploring Treatment Efficacy and Mechanism on Combining Immune Checkpoint Inhibitors PDL-1 and Targeted Therapy Drug Regorafenib of Glioblastoma
2020.08~2021.07 (Closed)
Ministry of Science and Technology (MOST)
Evaluation of therapeutic efficacy and underlying mechanism of regorafenib combine immune check point inhibitor
2020.08~2021.07 (Closed)
Ministry of Science and Technology (MOST)
Evaluate therapeutic efficacy and underlying mechanism of lenvatinib combined radiation on hepatocellular carcinoma
2019.08~2022.07 (Closed)
Ministry of Science and Technology (MOST)
利用多模式小動物進階磁振造影技術定量膠質母細胞瘤之研究
2018.08~2018.07 (Closed)
Ministry of Science and Technology (MOST)
Investigating potential MR biomarkers in a rat model of Alzheimer's disease at 7 T: from microstructural, pathophysiological, and molecular perspectives.
PI: Ping-Huei Tsai (Department of Medical Imaging and Radiological Sciences, CSMU)
Grant Number: MOST107-2314-B-040-027-
Budget: NTD 1,357,229
2018.01~2021.12 (Closed)
National Health Research Institutes (NHRI)
Multi-site Radiogenomics and Radioproteomics of Gliomas
PI: Cheng-Yu Chen (Taipei Medical University)
Grant Number: N04I107A
Budget: NTD 7,500,000
2017.11~2018.10 (Closed)
nology (MOST)
Construction and Application of Medical Image Database in TMU Healthcare System
Grant Number: 106-2634-F-038-002-
Budget: NTD 10,000,000
2016.01~2019.12 (Closed)
National Health Research Institutes (NHRI), Taiwan
Development of Industry for Personalized Genomic Medicine, Subproject 3: Precision Medicine on Brain Tumor
PI: Cheng-Yu Chen (Taipei Medical University)
Grant Number: MG-105-SP-07, MG-106-SP-07
2015.01~2017.12 (Closed)
Ministry of Health and Welfare (MOHW), Taiwan
Taipei Medical University, Center of Excellence for Cancer Research (CECR): Imaging Core
PI: Yun Yen (Taipei Medical University)
Grant Number: MOHW103-TD- B-111- 01, MOHW104-TDU- B-212- 124-001, MOHW105-TDU- B-212- 134001, MOHW106-TDU- B-212- 144001